SCHEMBL24398187

SCHEMBL24398187

c1ccc(-c2cc(-c3cc(-c4cc(-c5ccccn5)ccn4)cc(-c4cc(-c5ccccn5)ccn4)c3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 2/20 0.51
▸ ASIC3 Q9UHC3 1/20 0.47
▸ LMNA P02545 3/20 0.46
▸ CCR1 P32246 3/20 0.46
▸ CCR5 P51681 3/20 0.46
▸ CCR8 P51685 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ TP53 P04637 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ ALPL P05186 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ ALPI P09923 1/20 0.46
▸ ALPG P10696 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ CYP19A1 P11511 1/20 0.45
▸ DHODH Q02127 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19037259 0.97 TGFBR1 (0.49) TGFBR1ASIC3LMNACCR1CCR5
SCHEMBL12148384 0.93 KDM4E (0.52) TGFBR1ASIC3LMNACCR1CCR5
SCHEMBL12148388 0.91 CYP19A1 (0.53) TGFBR1ASIC3LMNACCR1CCR5
SCHEMBL17932365 0.90 KDM4E (0.50) TGFBR1LMNACCR1CCR5CCR8
SCHEMBL18961086 0.90 CYP19A1 (0.51) TGFBR1LMNACCR1CCR5CCR8
SCHEMBL17343429 0.90 CYP19A1 (0.51) TGFBR1LMNACCR1CCR5CCR8
SCHEMBL17343426 0.90 KDM4E (0.57) LMNACCR1CCR5CCR8KDM4E
SCHEMBL17343387 0.89 CYP19A1 (0.51) TGFBR1LMNACCR1CCR5CCR8
SCHEMBL17343428 0.88 KDM4E (0.52) LMNACCR1CCR5CCR8KDM4E
SCHEMBL17932831 0.88 CYP19A1 (0.53) TGFBR1ASIC3L3MBTL1SMN1; SMN2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223814-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-07-14 — — US disclosed
US-20220135601-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135601-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CYP1A1, CYP1B1 TGFBR1 1964/4885ASIC3 2870/4885LMNA 2518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback